KR20080005724A - Method for separation and purification of corosolic acid from corosolic acid-containing materials - Google Patents
Method for separation and purification of corosolic acid from corosolic acid-containing materials Download PDFInfo
- Publication number
- KR20080005724A KR20080005724A KR1020060064411A KR20060064411A KR20080005724A KR 20080005724 A KR20080005724 A KR 20080005724A KR 1020060064411 A KR1020060064411 A KR 1020060064411A KR 20060064411 A KR20060064411 A KR 20060064411A KR 20080005724 A KR20080005724 A KR 20080005724A
- Authority
- KR
- South Korea
- Prior art keywords
- corosolic acid
- methanol
- ethanol
- organic solvent
- acid
- Prior art date
Links
- FRWNAQDBODEVAL-VMPITWQZSA-N (5e)-5-[(4-nitrophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\1C(=O)NC(=S)S/1 FRWNAQDBODEVAL-VMPITWQZSA-N 0.000 title claims abstract description 94
- QNMKGMUGYVWVFQ-UHFFFAOYSA-N 2alpha-Hydroxyursolic acid Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3C(C)C(C)(C)CCC3(C(O)=O)CCC21C QNMKGMUGYVWVFQ-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 238000000034 method Methods 0.000 title claims abstract description 40
- 239000000463 material Substances 0.000 title claims abstract description 23
- 238000000746 purification Methods 0.000 title claims description 10
- 238000000926 separation method Methods 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 130
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 106
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000003960 organic solvent Substances 0.000 claims abstract description 26
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 24
- 241000196324 Embryophyta Species 0.000 claims abstract description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 14
- 238000004007 reversed phase HPLC Methods 0.000 claims abstract description 7
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 6
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 3
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 3
- 238000004114 suspension culture Methods 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- 239000008213 purified water Substances 0.000 claims description 33
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 241000218645 Cedrus Species 0.000 claims description 2
- 244000047670 Viola x wittrockiana Species 0.000 claims description 2
- 235000004031 Viola x wittrockiana Nutrition 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- HFGSQOYIOKBQOW-ZSDYHTTISA-N corosolic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C HFGSQOYIOKBQOW-ZSDYHTTISA-N 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 17
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 16
- 238000001556 precipitation Methods 0.000 abstract description 5
- 240000003583 Ternstroemia japonica Species 0.000 abstract description 2
- 241000879313 Tiarella polyphylla Species 0.000 abstract description 2
- 238000004113 cell culture Methods 0.000 abstract description 2
- 235000017159 Crataegus pinnatifida Nutrition 0.000 abstract 1
- 241000657480 Crataegus pinnatifida Species 0.000 abstract 1
- 244000198896 Lagerstroemia speciosa Species 0.000 abstract 1
- 239000011343 solid material Substances 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 15
- 238000011084 recovery Methods 0.000 description 10
- 238000004440 column chromatography Methods 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 241001092070 Eriobotrya Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000532927 Lagerstroemia Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- -1 and preferably Chemical compound 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Pediatric Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
Description
도 1은 본 발명의 실시예 1 에서의 에탄올 유기용매 추출 후, 추출 건고물에 대한 고속액체 크로마토그래피(HPLC) 분석결과이다. FIG. 1 is a result of high performance liquid chromatography (HPLC) analysis of an extract dried after ethanol organic solvent extraction in Example 1 of the present invention.
도2a는 본 발명의 실시예 2에서 실시한 에탄올 추출물을 에탄올/정제수를 이동상으로하여 역상 크로마토그래피 후 HPLC 분석결과이다.Figure 2a is the ethanol extract carried out in Example 2 of the present invention after reversed phase chromatography using ethanol / purified water as the mobile phase HPLC analysis.
도 2b는 본 발명의 실시예 3에서 실시한 에탄올/정제수 침전 후 HPLC 분석결과이다.2b is an HPLC analysis result after ethanol / purified water precipitation performed in Example 3 of the present invention.
도3은 본 발명의 실시예 4에서 실시한 활성분획을 전개용매로 에탄올을 사용하여 고속액체 크로마토그래피 후 HPLC 분석결과이다. Figure 3 shows the results of HPLC analysis after high performance liquid chromatography using ethanol as the developing solvent of the active fraction carried out in Example 4 of the present invention.
[산업상 이용분야][Industrial use]
본 발명은 코로솔릭산 함유물질로부터 코로솔릭산을 고수율 및 고순도로 추출 및 정제하는 방법에 관한 것으로, 보다 상세하게는, 유기용매를 이용하여 코로 솔릭산 함유물질로부터 코로솔릭산을 추출한 후 농축하여 건고하는 단계; 상기에서 얻은 농축 건고물을 크로마토그래피 또는 재결정에 의하여 정제하는 단계; 상기 반응 생성물을 고속액체 크로마토그래피에 의하여 정제하는 단계를 포함하는 코로솔릭산의 정제 방법에 관한 것이다. The present invention relates to a method for extracting and purifying corosolic acid from a corosolic acid-containing substance in high yield and high purity. More specifically, the extract is concentrated after extracting corosolic acid from a corosolic acid-containing substance using an organic solvent. To dry; Purifying the concentrated dried material obtained above by chromatography or recrystallization; It relates to a method for purifying corosolic acid comprising the step of purifying the reaction product by high performance liquid chromatography.
[종래 기술][Prior art]
코로솔릭산은 부처꽃과의 식물인 바나바, 장미과의 식물인 비파의 잎 및 산사나무의 과육 등에 존재하는 것으로 알려져 있으며, 이러한 식물은 동남아시아 전역에서 1500년 전부터 음용하여 당뇨병 예방 및 치료로 널리 사용되어 온 약용식물로서, 일본에서도 차의 형태로 상품화되고 있으며 그 안정성도 확인되고 있다. Corosolic acid is known to be present in the banaba, a family of budaceae, the leaves of loquat, a rose family, and the flesh of hawthorn. These plants have been widely used for the prevention and treatment of diabetes since 1500 years throughout Southeast Asia. As a plant, it is commercialized in the form of tea in Japan, and its stability is also confirmed.
코로솔릭산은 인슐린과 유사하게 세포막의 포도당 수송 경로을 활성화시켜 혈당치를 저하시키는 역할을 하는 물질로 [Chem.pham.Bull. 41(12) 2129-2131 (1993)], 이 후 임상 실험에서 코로솔릭산이 부작용 없이 혈당을 낮출 뿐만 아니라, 혈당치의 재상승을 억제하고 (Jounrnal of Ethnophamacology 87(2003) 115-117), 체중 조절에도 중요한 역할을 하는 것으로도 알려져 있다 (미국특허 등록 제6,78,4206호). 그러나 이 물질의 공급은 주로 바나바, 비파 등의 식물체로부터 직접 열 추출 및 알코올 추출에 의하여 생산 되므로, 그 함량이 매우 낮아 고순도 정제에 많은 어려움이 있다. 더욱이, 건강식품 및 의약품 등에서의 코로솔릭산의 수요가 증가하는 추세에 불구하고, 이러한 낮은 생산성의 제한에 의하여, 코로솔릭산의 공급에 여러 가지 문제점이 있어 왔다.Corosolic acid is a substance that acts to lower the blood sugar level by activating the glucose transport pathway of the cell membrane similar to insulin [Chem.pham.Bull. 41 (12) 2129-2131 (1993)], and in subsequent clinical trials, corosolic acid not only lowers blood sugar without side effects, but also suppresses the rise in blood sugar levels (Jounrnal of Ethnophamacology 87 (2003) 115-117), It is also known to play an important role (US Pat. No. 6,78,4206). However, the supply of this material is mainly produced by direct heat extraction and alcohol extraction from plants such as banaba, loquat, etc., the content is very low, there are many difficulties in high purity purification. Moreover, despite the trend of increasing demand for corosolic acid in health foods and medicines, there have been various problems in the supply of corosolic acid due to such low productivity limitation.
미국특허등록 제6,485,760호에서는 바나바의 잎으로부터 에탄올 수용액, 메 탄올 수용액 또는 뜨거운 물을 이용하여 추출한 후, 활성탄을 처리하여 색소를 제거한 0.1 내지 15%의 코로솔릭산 함량을 가지는 건고물을 이용하여 임상 실험을 수행한 바 있다. 그러나 제시된 방법은 추출에 의한 저순도의 코로솔릭산을 얻기 위한 방법이며, 의약품으로 사용하기 위해서는 고순도의 코로솔릭산이 필요하므로, 그 이용에 한계가 있다. In US Pat. No. 6,485,760, a ethanol solution, methanol solution, or hot water is extracted from the leaves of Banaba and then dried using a dry matter having a content of 0.1-15% corosolic acid from which activated pigments are removed to remove pigments. The experiment was performed. However, the proposed method is a method for obtaining low-purity corosolic acid by extraction, and high purity corosolic acid is required for use as a medicine, and thus there is a limit to its use.
미국공개특허 제2003/0165581호에서는 Prunella Linn 또는 Rabdosis(Blumn)Hasskarl의 식물체에 대하여 에탄올 등의 극성용매를 이용한 추출을 수행하고, 이 추출된 물질을 petroleum ether와 물을 이용하여 분배시킨 후, 1% 내외의 코로솔릭산 추출물을 얻고, 한 번 이상의 컬럼 크로마토그래피(column chromatography)와 두 번의 재결정을 수행하여, 98%이상의 코로솔릭산을 얻는 방법이 개시되어 있다. 이 경우, 상기 식물의 성장 주기가 바나바 잎에 비해 짧아서 동시간 내에 상대적으로 많은 양의 코로솔릭산의 수득이 가능하지만, 이 또한 식물체로부터 분리하는 방법으로 산업적 규모의 생산에 한계가 있다. 또한, 수율면에서 보면, 첫 단계의 에탄올 추출 단계에서 10 내지 15% 이상, 분배 단계에서 5% 이상의 낮은 수율을 보일 뿐 아니라, 여러 번의 컬럼 크로마토그래피(column chromatography)와 재결정으로 공정이 복잡하여, 고순도의 코로솔릭산을 얻기 위해서는 많은 시간과 노력이 요구되는 단점이 있다.In US 2003/0165581, Prunella Linn or Rabdosis (Blumn) Hasskarl plants were subjected to extraction using a polar solvent such as ethanol, and the extracted materials were distributed using petroleum ether and water, and then 1 A method of obtaining a corosolic acid extract of about% and performing at least one column chromatography and two recrystallizations to obtain at least 98% of the corosolic acid is disclosed. In this case, the growth cycle of the plant is shorter than that of the banaba leaves, so that it is possible to obtain a relatively large amount of corosolic acid within the same time, but this also has a limitation on industrial scale production by separating from the plant. In addition, in terms of yield, the yield is not only 10-15% or more in the first ethanol extraction step, but 5% or more in the dispensing step, and the process is complicated by several column chromatography and recrystallization. There is a disadvantage that requires a lot of time and effort to obtain high purity corosolic acid.
코로솔릭산의 전구체인 울소릭산으로부터 반합성하여 코로솔릭산을 생산하는 방법(미국 공개특허 제2005/0020681호)이 발표되었으나, 이 역시, 전구체인 울소릭산을 천연의 식물로부터 추출하는 것이어서 공급에 한계가 있으며 다시 합성을 해 야 하는 등 경제적인 면에서 비효율적이다. 또한 생산성은 천연의 잎에 존재하는 코로솔릭산의 함량과 유사한 낮은 수준으로 판단된다.A method of producing corosolic acid by semi-synthesis from ulsoric acid, which is a precursor of corosolic acid, has been published (US Patent Publication No. 2005/0020681), but this is also limited to supply because it is extracted from a natural plant, which is a precursor of ulsoric acid. It is economically inefficient, such as having to synthesize again. In addition, productivity is judged to be at a low level similar to the content of corosolic acid present in natural leaves.
이와 같은 종래의 기술은 건강식품 및 의약품 등 산업에서의 코로솔릭산 수요증가에도 불구하고 고순도의 코로솔릭산을 생산하는데 매우 비효율적이고, 낮은 생산성으로 인해 그 생산이 제한되고 있는 실정이다. 따라서 생리활성물질인 코로솔릭산을 고순도로 효율적인 방법으로 생산하는 방법에 대한 기술 개발이 절실히 요구되고 있다.Such a conventional technology is very inefficient in producing high purity corosolic acid despite increasing demand for corosolic acid in industries such as health food and pharmaceuticals, and its production is limited due to low productivity. Therefore, there is an urgent need for the development of a technique for producing a bioactive substance corosolic acid in a high purity and efficient manner.
본 발명은, 상기와 같은 문제점을 해결하기 위한 것으로서, 코로솔릭산 함유물질로부터 코로솔릭산을 고순도로 및 고수율로 추출 정제하는 방법을 제공하는 것이다.The present invention is to solve the above problems, to provide a method for extracting and purifying corosolic acid in high purity and high yield from the corosolic acid-containing material.
또한, 본 발명의 또 다른 목적은 1종 이상의 유기 용매만을 이용하는 단순화된 공정으로 코로솔릭산을 고순도 및 고수율로 분리 정제하는 방법을 제공하는 것이다.Still another object of the present invention is to provide a method for separating and purifying corosolic acid in high purity and high yield in a simplified process using only one or more organic solvents.
본 발명은 코로솔릭산 함유물질로부터 코로솔릭산을 고수율 및 고순도로 추출 및 정제하는 방법에 관한 것으로, 보다 상세하게는, 유기용매를 이용하여 코로솔릭산 함유물질로부터 코로솔릭산을 추출한 후 농축하여 건고하는 단계; 상기에서 얻은 농축 건고물을 크로마토그래피 또는 재결정에 의하여 정제하는 단계; 상기 반응 생성물을 고속액체 크로마토그래피에 의하여 정제하는 단계를 포함하는 코로솔 릭산의 정제 방법에 관한 것이다. The present invention relates to a method for extracting and purifying corosolic acid from a corosolic acid-containing material in high yield and high purity. To dry; Purifying the concentrated dried material obtained above by chromatography or recrystallization; It relates to a method for purifying corosolic acid comprising the step of purifying the reaction product by high performance liquid chromatography.
본 발명에 따라 추출 정제된 코로솔릭산을 수득하기 위한 출발물질로서 ‘코로솔릭산 함유물질’이란 모든 코로솔릭산을 생산하는 것으로 알려진 식물 종, 이로부터 유도된 캘러스, 식물 세포, 및 식물 세포 현탁 배양액을 모두 포함한다. 상기의 코로솔릭산을 생산하는 것으로 알려진 식물의 예로서, 바나바(Lagerstroemia speciosa), 비파(Eribotrya japonica), 후피향나무(Ternstroemia gymnanthera), 산사나무 (Crataegus pinnatifida), 헐떡이풀(Tiarella polyphylla) 등을 들 수 있으나, 이에 한정되는 것은 아니다. 사용되는 부위는 제한이 없으며, 식물체 전체, 잎, 과육, 줄기, 뿌리, 꽃 등을 모두 사용할 수 있고, 이 중에서도 잎 부위를 사용하는 것이 가장 좋다.As a starting material for obtaining extracted and purified corosolic acid according to the present invention, 'corosolic acid-containing substance' is a plant species known to produce all corosolic acid, callus derived from it, plant cells, and plant cell suspension. Include all cultures. An example of a plant known to produce the above corosolic acid is Lagerstroemia. speciosa ), loquats ( Eribotrya japonica ), cedar ( Ternstroemia gymnanthera ), hawthorn ( Crataegus) pinnatifida ), pansy ( Tiarella polyphylla ) and the like, but is not limited thereto. The area used is not limited, and the whole plant, leaves, pulp, stems, roots, flowers and the like can be used, and among these, it is best to use the leaf area.
보다 구체적으로, 본 발명의 한 구체예에 있어서, 본 발명의 코로솔릭산의 추출 및 정제 방법은,More specifically, in one embodiment of the present invention, the method of extracting and purifying the corosolic acid of the present invention,
(a) 코로솔릭산 함유 물질에 유기용매를 첨가하여 추출한 후 추출액을 농축하여 건고하는 단계;(a) extracting by adding an organic solvent to the corosolic acid-containing material and concentrating and drying the extract;
(b1) 상기 단계 (a)에서 얻은 건고물을 유기용매에 녹인 후, 순상 크로마토그래피를 수행하여 활성 분획을 얻는 단계; 및(b1) dissolving the dried product obtained in step (a) in an organic solvent, and then performing normal phase chromatography to obtain an active fraction; And
(c) 상기 단계 (b1)에서 얻어진 활성분획에 대하여 고속액체 역상 크로마토그래피를 수행하여, 상기 활성 분획 내의 코로솔릭산을 정제하는 단계를 포함하는 것일 수 있다.(c) performing high-performance liquid reverse phase chromatography on the active fraction obtained in step (b1) to purify the corosolic acid in the active fraction.
본 발명의 또 다른 구체예에 있어서, 본 발명의 코로솔릭산의 추출 및 정제 방법은,In another embodiment of the present invention, the method of extracting and purifying the corosolic acid of the present invention,
(a) 코로솔릭산 함유물질에 유기용매를 첨가하여 추출한 후 추출액을 농축하여 건고하는 단계;(a) extracting by adding an organic solvent to the corosolic acid-containing material and concentrating and drying the extract;
(b1') 상기 단계 (a)에서 얻은 건고물을 유기용매에 녹인 후, 역상 크로마토그래피를 수행하여 활성 분획을 얻는 단계; 및(b1 ') dissolving the dried product obtained in step (a) in an organic solvent, and then performing reversed phase chromatography to obtain an active fraction; And
(c) 상기 단계 (b1')에서 얻어진 활성분획에 대하여 고속액체 역상 크로마토그래피를 수행하여, 상기 활성 분획 내의 코로솔릭산을 정제하는 단계를 포함하는 것일 수 있다.(c) performing high-performance liquid reverse phase chromatography on the active fraction obtained in step (b1 '), and may comprise the step of purifying corosolic acid in the active fraction.
본 발명의 또 다른 구체예에 있어서, 본 발명의 코로솔릭산의 추출 및 정제 방법은,In another embodiment of the present invention, the method of extracting and purifying the corosolic acid of the present invention,
(a) 코로솔릭산 함유물질에 유기용매를 첨가하여 추출한 후 추출액을 농축하여 건고하는 단계;(a) extracting by adding an organic solvent to the corosolic acid-containing material and concentrating and drying the extract;
(b2) 상기 단계 (a)에서 얻은 건고물을 에탄올, 메탄올 및 아세톤으로 이루어진군 중에서 선택된 용매에 용해시킨 후, 상기 용액에 정제수를 가하여 침전시키는 단계; 및(b2) dissolving the dried material obtained in step (a) in a solvent selected from the group consisting of ethanol, methanol and acetone, and then precipitating by adding purified water to the solution; And
(c) 상기 단계 (b2)에서 생성된 침전물에 대하여 고속액체 역상 크로마토그래피를 수행하여, 상기 침전물 내의 코로솔릭산을 정제하는 단계를 포함하는 것일 수 있다.(c) performing high-performance liquid reverse phase chromatography on the precipitate produced in the step (b2), and may include the step of purifying the corosolic acid in the precipitate.
상기 단계 (a)에서 코로솔릭산 함유물질에 첨가하는 유기용매로는, 메탄올, 에탄올, 프로판올, 이소프로판올 및 부탄올 등을 포함하는 탄소수 1 내지 5 개의 저급 알코올류 중에서 선택하여 사용할 수 있으며, 바람직하게는, 메탄올 또는 에탄올을 사용할 수 있다. 상기 알코올은 100% 알코올 상태, 또는 농도 10 이상 100% (v/v) 미만의 수용액 상태로 사용할 수 있다. 본 명세서에 있어서, 특별한 언급이 없는 한, '알코올 수용액'은 알코올과 물의 혼합물 및 알코올 100%인 경우를 모두 포함하는 것으로 정의한다. 알코올을 사용하여 추출하는 경우, 알코올 농도가 높을수록 추출 효율이 좋아지며, 효과적인 추출을 위한 최소 알코올 농도는 10% (v/v) 이다. 예컨대, 메탄올, 에탄올, 또는 프로판올을 사용하여 추출하는 경우, 상기 알코올 수용액은 농도가 10 내지 100% (v/v)인 것을 사용할 수 있으며, 보다 우수한 추출 효율을 얻기 위하여 농도 80 내지 100% (v/v) 인 것이 바람직하며, 농도 100%인 것이 가장 바람직하다. 상기 단계 (a)에서 유기용매로서 사용되는 알코올 또는 알코올 수용액의 양은 코로솔릭산 함유 물질 건조 중량을 기준으로 20 내지 3000% (v/w)일 수 있으며, 100 내지 2000%(v/w)인 것이 바람직하다. 유기용매로서 사용되든 알코올 또는 알코올 수용액의 사용량이 20% 이하이면 건고물 대비 알코올량이 너무 적어 추출이 어려우며, 3000% (v/w)이상은 사용이 가능하나 용매 사용량이 지나치게 많아져 경제성이 떨어지는 문제점이 있다.As the organic solvent added to the corosolic acid-containing material in step (a), it can be selected from among lower alcohols having 1 to 5 carbon atoms including methanol, ethanol, propanol, isopropanol and butanol, and preferably , Methanol or ethanol can be used. The alcohol may be used in the state of 100% alcohol, or in an aqueous solution at a concentration of 10 or more and less than 100% (v / v). In the present specification, unless otherwise specified, the 'alcohol aqueous solution' is defined as including both the mixture of alcohol and water and the case of 100% alcohol. In the case of extraction using alcohol, the higher the alcohol concentration, the better the extraction efficiency, and the minimum alcohol concentration for effective extraction is 10% (v / v). For example, when extracted using methanol, ethanol, or propanol, the alcohol aqueous solution may be used in a concentration of 10 to 100% (v / v), in order to obtain a better extraction efficiency concentration of 80 to 100% (v / v), with a concentration of 100% being most preferred. The amount of the alcohol or aqueous alcohol solution used as the organic solvent in the step (a) may be 20 to 3000% (v / w) based on the dry weight of the corosolic acid-containing material, 100 to 2000% (v / w) It is preferable. When used as an organic solvent, if the amount of alcohol or an aqueous solution of alcohol is less than 20%, the amount of alcohol is too low compared to the dry matter, making extraction difficult, and more than 3000% (v / w) can be used, but the amount of solvent used is too high, resulting in poor economic efficiency. There is this.
코로솔릭산의 충분한 추출을 위하여, 상기 단계 (a)의 추출은 15℃ 내지 80℃의 온도에서 50 내지 300 rpm의 교반속도로 30분 내지 48시간 동안 교반하여 수행하는 것이 좋다. 또한, 3회 정도 추출하면 추출 효율이 80% 이상이며, 5회 정도 추출하면 100%에 가까운 추출 효율을 얻을 수 있다. 따라서 추출횟수는 1회 내지 5회 반복하는 것이 좋다. 이와 같이 추출된 코로솔릭산은 25 내지 35℃ 물 중탕에 서 감압 농축 후 약 35℃에서 진공 건조하여 건고한다.For sufficient extraction of corosolic acid, the extraction of step (a) is preferably carried out by stirring for 30 minutes to 48 hours at a stirring speed of 50 to 300 rpm at a temperature of 15 ℃ to 80 ℃. In addition, the extraction efficiency is 80% or more when extracted about three times, and extraction efficiency close to 100% can be obtained by extracting about five times. Therefore, the number of extraction is good to repeat 1 to 5 times. The extracted corosolic acid is concentrated under reduced pressure in a water bath of 25 to 35 ℃ and dried by vacuum drying at about 35 ℃.
상기와 같이 얻어진 코로솔릭산 추출물을 단계 (b1), 또는 (b1')에 따라 순상 또는 역상 컬럼 크로마토그래피를 수행하여 정제하거나, 단계 (b2)에 따라 메탄올, 에탄올 및 아세톤으로 이루어진 군 중에서 선택된 유기용매에 용해시킨 후 정제수를 가하여 침전시켜 정제할 수 있다. 바람직하게는, 역상 크로마토그래피에 의하여 정제하는 것이 좋다. The corosolic acid extract obtained as described above is purified by performing normal phase or reverse phase column chromatography according to step (b1) or (b1 '), or organic selected from the group consisting of methanol, ethanol and acetone according to step (b2). After dissolving in a solvent it can be purified by adding purified water to precipitate. Preferably, purification by reverse phase chromatography is preferred.
(b1) 또는 (b1')에 있어서, 단계 (a)에서 얻어진 건고물이 상기 건고물 중량 1 g을 기준으로 50 내지 200 배 부피의 탄소수 1 내지 5인 저급 알코올, 클로로포름, 디클로로메탄, 벤젠, 아세톤, 헥산 및 에틸아세테이트로 이루어진 군 중에서 선택된 1종 이상의 유기용매에 충분히 용해된 용액을 사용하여 크로마토그래피를 수행할 수 있다. (b1) or (b1 '), the dried material obtained in step (a) is a lower alcohol, chloroform, dichloromethane, benzene, having 1 to 5 carbon atoms in a volume of 50 to 200 times based on 1 g of the dry weight. Chromatography may be performed using a solution sufficiently dissolved in one or more organic solvents selected from the group consisting of acetone, hexane and ethyl acetate.
순상 컬럼 크로마토그래피로 정제하는 경우, 컬럼의 충진제로는 실리카겔, 전분, 규조토분말, 셀룰로오스 등을 사용할 수 있다. 실리카겔을 사용하는 경우, 컬럼 크로마토그래피에 통상적으로 사용되는 실리카겔, 예컨대, 실리카겔 40(63~200㎛), 실리카겔 60(63~200㎛), 실리카겔 60F254(200~500㎛) 등을 사용할 수 있다. 전개용매로는 클로로포름, 메탄올, 디클로로메탄, 벤젠, 아세톤, 헥산 및 에틸아세테이트로 이루어진 군으로부터 1종 이상의 유기용매를 선택할 수 있다. 고순도의 코로솔릭산을 얻기 위하여 가장 바람직한 전개 용매로서 메탄올과 클로로포름이 2 내지 50:98 내지 50 (메탄올 부피:클로로포름 부피)의 부피비로 혼합된 혼합용매를 사용할 수 있으며, 메탄올 및 클로로포름 부피비가 5:95 (메탄올 부피: 클로로포름 부피)인 혼합 용매가 가장 바람직하다.In the case of purification by normal phase column chromatography, silica gel, starch, diatomaceous earth powder, cellulose or the like may be used as the filler of the column. In the case of using silica gel, silica gel commonly used for column chromatography, for example, silica gel 40 (63 to 200 μm), silica gel 60 (63 to 200 μm), silica gel 60F254 (200 to 500 μm) and the like can be used. As the developing solvent, one or more organic solvents may be selected from the group consisting of chloroform, methanol, dichloromethane, benzene, acetone, hexane and ethyl acetate. In order to obtain high purity corosolic acid, a mixed solvent in which methanol and chloroform are mixed in a volume ratio of 2 to 50:98 to 50 (methanol volume: chloroform volume) may be used as a most preferable developing solvent, and a methanol and chloroform volume ratio of 5: Most preferred is a mixed solvent of 95 (methanol volume: chloroform volume).
역상 컬럼 크로마토그래피를 이용하여 정제할 경우, 컬럼의 충진제로는 ODS (Octadecylsilylated, C18), C8, C4, CN 또는 phenyl 등을 사용할 수 있고, 바람직하게는 ODS (Octadecylsilylated, C18, 40~100㎛)를 사용할 수 있다. 전개용매로서 메탄올, 에탄올, 아세토나이트릴, 물 등으로 이루어진 군 중에서 선택된 1 종 이상을 사용할 수 있다. 고순도의 코로솔릭산을 얻기 위하여, 70 내지 100%(v/v)메탄올/물, 또는 55 내지 100%(v/v)에탄올/물을 사용하는 것이 바람직하고, 85%(v/v)메탄올/물, 또는 65%(v/v)에탄올/물을 사용하는 것이 특히 바람직하다. When purified by reverse phase column chromatography, the filler of the column may be ODS (Octadecylsilylated, C18), C8, C4, CN or phenyl, etc., preferably ODS (Octadecylsilylated, C18, 40 ~ 100㎛) Can be used. As the developing solvent, one or more selected from the group consisting of methanol, ethanol, acetonitrile, water and the like can be used. In order to obtain high purity corosolic acid, it is preferable to use 70 to 100% (v / v) methanol / water, or 55 to 100% (v / v) ethanol / water, and 85% (v / v) methanol Particular preference is given to using / water or 65% (v / v) ethanol / water.
또한, 단계 (b2)에서는 단계 (a)에서 얻은 추출 건고물을 에탄올, 메탄올 또는 아세톤을 가하여 용해시키고, 정제수를 가하여 침전을 형성시킴으로써, 정제할 수 있다. 이 때, 에탄올, 메탄올 또는 아세톤 1ml 당 상기 건고물 1 내지 10 mg을 용해시킬 수 있다. 용매량이 너무 적으면 코로솔릭산의 수율이 낮아지므로, 우수한 수율로 코로솔릭산을 얻기 위해서 용매 1ml 당 건고물 함량이 1 mg 이상인 것이 좋고, 용매량이 너무 많으면 코로솔릭산의 순도가 낮아지므로, 고순도의 코로솔릭산을 얻기 위해서는 용매 1ml 당 건고물 함량이 10 mg 이하인 것이 좋다. 상기 정제수는 메탄올 또는 아세톤 부피 1에 대하여 0.1 내지 0.9 부피비 (메탄올 또는 아세톤 부피:정제수 부피 = 1:0.1 내지 0.9)로, 바람직하게는 1:0.3 내지 0.6 부피비로 첨가할 수 있고, 에탄올 부피 1 대하여서는 0.5 내지 1.5 부피비 (에탄올 부피:정제수 부피 = 1: 0.5 내지 1.5)로, 바람직하게는 1: 0.8 내지 1.2의 부피비로 첨가할 수 있다. 정제수의 비율이 높아질수록 순도가 낮아지는 경향이 있으며, 비율 이 낮아지면 수율이 낮아지게 되므로, 상기와 같은 부피비 범위로 사용하는 것이 바람직하다.Further, in step (b2), the extract dried product obtained in step (a) can be dissolved by adding ethanol, methanol or acetone, and purified by adding purified water to form a precipitate. At this time, 1 to 10 mg of the dry matter may be dissolved per 1 ml of ethanol, methanol or acetone. If the amount of solvent is too low, the yield of corosolic acid is lowered. Therefore, in order to obtain corosolic acid in an excellent yield, the dry matter content per 1 ml of solvent is preferably 1 mg or more. If the amount of solvent is too high, the purity of corosolic acid is lowered, so that high purity In order to obtain the corosolic acid, the dry matter content per 1 ml of solvent is preferably 10 mg or less. The purified water may be added in a 0.1 to 0.9 volume ratio (methanol or acetone volume: purified water volume = 1: 0.1 to 0.9) relative to methanol or acetone volume 1, preferably in a ratio of 1: 0.3 to 0.6 volume, and for ethanol volume 1 Can be added in a volume ratio of 0.5 to 1.5 (ethanol volume: purified water volume = 1: 0.5 to 1.5), preferably in a volume ratio of 1: 0.8 to 1.2. The higher the ratio of purified water, the lower the purity, and the lower the ratio, the lower the yield, so it is preferable to use it in the above volume ratio range.
정제수를 첨가한 후 침지온도 및 기간은 한정되지 않으며, 수율, 소요 시간에 비한 효율성 등을 고려하여, 침전시간은 1 시간 내지 4일인 것이 좋고, 바람직하게는 1 시간 내지 1일이 좋다. 침지 온도는 과도한 가온 또는 냉각이 필요 없는 온도 범위에서 가능하며, 예컨대, 0 내지 30℃, 바람직하게는 4 내지 25℃로 할 수 있다.After addition of purified water, the immersion temperature and duration are not limited, and in consideration of yield, efficiency compared to the required time, and the like, the settling time is preferably 1 hour to 4 days, and preferably 1 hour to 1 day. Immersion temperature is possible in the temperature range which does not need excessive heating or cooling, for example, can be 0-30 degreeC, Preferably it is 4-25 degreeC.
상기 단계 (c)에서는 단계 (b1), (b1'), 또는 (b2)에서 얻은 활성분획을 고속액체 크로마토그래피에 의해 정제한다. 상기 단계 (c)의 역상 고속액체 크로마토그래피의 전개용매로서 메탄올, 에탄올, 아세토나이트릴, 물 등으로 이루어진 군 중에서 선택된 1 종 이상을 사용할 수 있다. 상기 단계 (C)에서 소수성 수지 컬럼 고속액체 크로마토그래피를 사용할 수 있으며, 이 경우 비극성 불순물을 제거하는 ODS (Octadecylsilylated, C18), C8 또는 C4 등을 충진한 역상 고속액체 크로마토그래피를 전개용매로서 70 내지 85%(v/v) 메탄올/정제수 또는 55 내지 75%(v/v) 에탄올/정제수를 사용하여 수행함으로써, 95% 이상의 고순도의 코로솔릭산을 얻을 수 있다.In step (c), the active fraction obtained in step (b1), (b1 '), or (b2) is purified by high performance liquid chromatography. At least one selected from the group consisting of methanol, ethanol, acetonitrile, water, and the like may be used as a developing solvent for reverse phase high performance liquid chromatography in step (c). In step (C), hydrophobic resin column high performance liquid chromatography may be used, and in this case, reverse phase high performance liquid chromatography filled with ODS (Octadecylsilylated, C18), C8, or C4 to remove nonpolar impurities may be used as a developing solvent. By performing with 85% (v / v) methanol / purified water or 55-75% (v / v) ethanol / purified water, high purity corosolic acid of at least 95% can be obtained.
본 발명의 코로솔릭산 함유물질로부터 코로솔릭산을 추출 정제하는 방법에 있어서, 정제 단계 (b1 또는 b2)에 따라 각 단계별로 수득할 수 있는 코로솔릭산의 순도 및 회수율 범위는 하기의 표 1에 나타낸 바와 같다. In the method for extracting and purifying corosolic acid from the corosolic acid-containing material of the present invention, the purity and recovery range of the corosolic acid that can be obtained in each step according to the purification step (b1 or b2) are shown in Table 1 below. As shown.
상기 표 2에 나타낸 바와 같이, 본 발명의 코로솔릭산의 추출 및 정제 방법에 따르면, 순도 90% 이상의 고순도 코로솔릭산을 40% 이상의 고수율로 얻을 수 있게 된다.As shown in Table 2, according to the method for extracting and purifying the corosolic acid of the present invention, it is possible to obtain a high purity corosolic acid having a purity of 90% or more with a high yield of 40% or more.
본 명세서에서 코로솔릭산의 순도 및 회수율은 표 2의 조건에서 HPLC(고속액체크로마토그래피)를 사용하여 정량 분석하여 계산하였다.Purity and recovery of corosolic acid herein was calculated by quantitative analysis using HPLC (High Performance Liquid Chromatography) under the conditions of Table 2.
[[ 실시예Example ]]
이하, 실시예를 통해 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention more specifically, and the scope of the present invention is not limited to these examples.
실시예Example 1: 식물 세포배양액의 유기용매 추출 1: Organic Solvent Extraction from Plant Cell Culture Solution
대한민국 특허출원 제10-2005-0058377호 에 의해 제조한 비파 또는 바나바 등에서 유래된 세포주(KCTC 10822BP, KCTC 10823BP)를 배양하여 얻은 식물 세포를 회수하여 50℃에서 48시간 열풍 건조한다. 건고된 식물세포 100g을 100% 메탄올, 100% 에탄올, 80%(v/v) 에탄올/정제수 수용액 2000ml를 각각 가하고 상온 또는 80℃에서 1시간 교반하여 여과하는 과정을 4회 반복하여 추출액을 얻은 후, 감압 농축 및 건조하여 추출 건고물을 얻었다. 이와 같이 얻어진 추출 건고물에 대하여 고속액체 크로마토그래피 (HPLC)로 분석한 결과를 도 1에 나타내었다. 상기 결과에 의하여 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 3에 나타내었다.Plant cells obtained by culturing cell lines (KCTC 10822BP, KCTC 10823BP) derived from loquat or banaba prepared by Korean Patent Application No. 10-2005-0058377 were collected and dried by hot air at 50 ° C for 48 hours. 100 g of dried plant cells were added to 100% methanol, 100% ethanol, and 2000 ml of 80% (v / v) ethanol / purified water solution, respectively, and the mixture was stirred at room temperature or 80 ° C. for 1 hour and filtered to obtain an extract. Then, the mixture was concentrated under reduced pressure and dried to obtain an dried product. The extracted dry matter thus obtained was analyzed by high performance liquid chromatography (HPLC), and the results are shown in FIG. 1. The purity and yield of corosolic acid obtained by the above results are shown in Table 3 below.
실시예Example 2: 크로마토그래피에 의한 2: by chromatography 건고물의Dry matter 정제 refine
실시예Example 2-1. 2-1. 순상Chastity 컬럼column 크로마토그래피 Chromatography
상기 실시예 1의 실험번호 A에서 얻어진 메탄올 추출물 300mg을 20 ml의 클로로포름으로 녹인 후, 평형상과 이동상으로 5%(v/v) 메탄올/클로로포름을 이용하여 실리카겔 60N(timely사, Japan)이 충진된 직경 14mm 길이 400mm 컬럼에 아이소크래틱(isocratic) 방법으로 적용하여 순상 크로마토그래피를 수행하였다. 그 결과 순도가 34%인 활성분획을 수율 72.6%로 얻었다.After dissolving 300 mg of the methanol extract obtained in Experiment No. A of Example 1 with 20 ml of chloroform, silica gel 60N (timely, Japan) was filled with 5% (v / v) methanol / chloroform in equilibrium and mobile phases. Phase chromatography was performed by applying an isocratic method to a 14 mm diameter 400 mm long column. As a result, an active fraction having a purity of 34% was obtained with a yield of 72.6%.
실시예Example 2-2. 2-2. 역상Reverse 컬럼column 크로마토그래피-메탄올 Chromatography-Methanol
상기 실시예 1의 실험번호 A에서 얻어진 메탄올 추출물 300mg을 30ml의 100% 메탄올에 80℃로 열을 가하여 녹인 후, 평형상과 이동상으로 80%, 85%, 90%(v/v)메탄올/정제수 용액을 각각 이용하여 ODS (timely사, 100um, Japan) 가 충진된 직경 15.5mm 길이 900mm 칼럼에 적용하여 역상 크로마토그래피를 수행하였다. 이와 같이 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 4에 나타내었다.300 mg of the methanol extract obtained in Experiment No. A of Example 1 was dissolved in 30 ml of 100% methanol by heating at 80 ° C., and then 80%, 85%, and 90% (v / v) methanol / purified water in the equilibrium and mobile phases. Reverse phase chromatography was performed by applying the solution to a 15.5 mm diameter 900 mm column filled with ODS (timely, 100 um, Japan). The purity and yield of the corosolic acid thus obtained are shown in Table 4 below.
실시예Example 2-3. 2-3. 역상Reverse 컬럼column 크로마토그래피-에탄올 Chromatography-ethanol
실시예 1의 실험번호 B에서 얻어진 에탄올 추출물 300mg을 30ml의 100% 에탄올에 80℃ 열을 가하여 녹인 후, 평형상과 이동상으로 60%, 65%, 70%(v/v) 에탄올/정제수를 각각 이용하여 ODS (timely사, 100um, Japen) 가 충진된 직경 15.5mm 길이 900mm 칼럼에 적용하여 역상 크로마토그래피를 수행하였다. 상기에서 얻어진 활성 분획에 대하여 HPLC를 수행하여 그 결과를 도 2a에 나타내었다. 이와 같이 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 5에 나타내었다.300 mg of the ethanol extract obtained in Experiment No. B of Example 1 was dissolved in 30 ml of 100% ethanol by heating at 80 ° C., and 60%, 65%, and 70% (v / v) ethanol / purified water were used as equilibrium and mobile phases, respectively. Reverse phase chromatography was performed by applying to a diameter 15.5mm long 900mm column filled with ODS (timely, 100um, Japen). HPLC was performed on the active fractions obtained above, and the results are shown in FIG. 2A. The purity and yield of the corosolic acid thus obtained are shown in Table 5 below.
실시예Example 3: 침전에 의한 3: by precipitation 건고물의Dry matter 정제 refine
실시예Example 3-1. 메탄올/ 3-1. Methanol / 정제수Purified water 침전 Sedimentation
실시예 1의 실험번호 A에서 얻어진 메탄올 추출물 50mg에 메탄올 5ml을 가하여 용해시킨 후, 정제수 1.0 ml, 1.5 ml, 2.0 ml, 및 2.5 ml을 각각 가하고, 4℃에서 24시간 방치하여 침전시켰다. 상기 용액을 여과하여 생성된 침전물을 회수하였다. 회수된 침전물이 코로솔릭산이며,이와 같이 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 6에 나타내었다.After dissolving 5 ml of methanol in 50 mg of the methanol extract obtained in Experiment No. A of Example 1, 1.0 ml, 1.5 ml, 2.0 ml, and 2.5 ml of purified water were added thereto, and the mixture was left at 4 ° C. for 24 hours to precipitate. The solution was filtered to recover the resulting precipitate. The recovered precipitate is corosolic acid, and the purity and yield of the corosolic acid thus obtained are shown in Table 6 below. Indicated.
실시예Example 3-2. 에탄올/ 3-2. ethanol/ 정제수Purified water 침전 Sedimentation
실시예 1의 실험번호 B에서 얻어진 에탄올 추출물 50mg에 에탄올 5ml을 가하여 용해시킨 후, 정제수 3.0 ml, 4.0 ml, 5.0 ml, 및 6.0 ml를 각각 가하고, 4℃에서 24시간 방치하여 침전시켰다. 상기 용액을 여과하여 생성된 침전물을 회수하였다. 상기 침전물에 대하여 HPLC를 수행하여 그 결과를 도 2b에 나타내었다. 이와 같이 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 7에 나타내었다. After dissolving 5 ml of ethanol in 50 mg of the ethanol extract obtained in Experiment No. B of Example 1, 3.0 ml, 4.0 ml, 5.0 ml, and 6.0 ml of purified water were added, and the mixture was left at 4 ° C. for 24 hours to precipitate. The solution was filtered to recover the resulting precipitate. HPLC was performed on the precipitate, and the result is shown in FIG. 2B. The purity and yield of the corosolic acid thus obtained are shown in Table 7 below.
실시예Example 3-3. 아세톤/ 3-3. Acetone / 정제수Purified water 침전 Sedimentation
실시예 1의 실험번호 A에서 얻어진 메탄올 추출물 50mg에 아세톤 5ml을 가하여 용해시킨 후, 정제수를 1.0 ml, 1.5 ml, 2.0 ml, 및 2.5ml을 각각 가하고, 4℃에서 24시간 방치하여 침전시켰다. 상기 용액을 여과하여 생성된 침전물을 회수하였다. 이와 같이 얻어진 코로솔릭산의 순도 및 수율을 하기의 표 8에 나타내었다. After dissolving 5 ml of acetone in 50 mg of the methanol extract obtained in Experiment No. A of Example 1, 1.0 ml, 1.5 ml, 2.0 ml, and 2.5 ml of purified water were added, and the mixture was left at 4 ° C. for 24 hours to precipitate. The solution was filtered to recover the resulting precipitate. The purity and yield of the corosolic acid thus obtained are shown in Table 8 below .
실시예Example 4: 고속액체 4: high speed liquid 역상크로마토그래피에In reversed phase chromatography 의한 by 코로솔릭산의Corosolic 정제 refine
실시예Example 4-1. 고속액체 4-1. High speed liquid 역상크로마토그래피Reversed phase chromatography -메탄올Methanol
실시예 2-2의 실험번호 G에서 얻은 활성분획을 감압 여과 및 35℃에서 진공 건조한 후, 100% 메탄올에 80℃ 열을 가하여 용해시켰다. 상기 용액을 ODS를 충진한 역상 고속액체크로마토그래피에 77.5% 메탄올/정제수를 사용하여 이소크래틱 방법으로 적용하여 크로마토그래피를 3회 수행하여 정제하였다. 그 결과, 순도 95%의 코로솔릭산을 수율 80%로 얻었다. The active fraction obtained in Experiment No. G of Example 2-2 was filtered under reduced pressure and dried in vacuo at 35 ° C., and then dissolved by heating at 80 ° C. in 100% methanol. The solution was purified by subjecting the ODS-filled reversed phase high performance liquid chromatography to isocratic method using 77.5% methanol / purified water three times by chromatography. As a result, corosolic acid having a purity of 95% was obtained in a yield of 80%.
실시예Example 4-2. 고속액체 4-2. High speed liquid 역상크로마토그래피Reversed phase chromatography -에탄올-ethanol
실시예 2-3의 실험번호 J에서 얻은 활성분획을 감압 여과 및 35℃에서 진공 건조한 후, 100% 에탄올에 80℃ 열을 가하여 용해시켰다. 상기 용액을 ODS를 충진한 역상 고속액체크로마토그래피에 65% 에탄올/정제수를 전개용매로 사용하여 이소크래틱 방법으로 적용하여 크로마토그래피를 3회 수행하여 정제하였다. 이와 같이 얻어진 코로솔릭산의 순도는 95%이고 수율은 80%이었다.The active fraction obtained in Experiment No. J of Example 2-3 was filtered under reduced pressure and vacuum dried at 35 ° C., and then dissolved by heating at 80 ° C. in 100% ethanol. The solution was purified by applying chromatography to ODS-filled reverse phase high performance liquid chromatography using isocratic method using 65% ethanol / purified water as a developing solvent. The purity of the corosolic acid thus obtained was 95% and the yield was 80%.
본 발명은, 코로솔릭산 정제에 있어서, 추출, 크로마토그래피, 침전, 고속액체 크로마토그래피 등의 방법을 실시하여 효율적으로 고순도의 코로솔릭산을 얻으므로써, 건강기능식품 및 의약품 소재로 산업적으로 이용 및 생산이 가능하다.Industrial Applicability In the present invention, in the purification of corosolic acid, extraction, chromatography, precipitation, high-performance liquid chromatography, etc., are performed efficiently to obtain high purity corosolic acid. Production is possible.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060064411A KR100901379B1 (en) | 2006-07-10 | 2006-07-10 | Method for separation and purification of corosolic acid from corosolic acid-containing materials |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060064411A KR100901379B1 (en) | 2006-07-10 | 2006-07-10 | Method for separation and purification of corosolic acid from corosolic acid-containing materials |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080005724A true KR20080005724A (en) | 2008-01-15 |
KR100901379B1 KR100901379B1 (en) | 2009-06-05 |
Family
ID=39215784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060064411A KR100901379B1 (en) | 2006-07-10 | 2006-07-10 | Method for separation and purification of corosolic acid from corosolic acid-containing materials |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100901379B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013021258A1 (en) | 2011-08-05 | 2013-02-14 | Council Of Scientific & Industrial Research | Anti-tubercular compounds |
CN104007223A (en) * | 2014-06-10 | 2014-08-27 | 山西振东开元制药有限公司 | Quality control method of hawthorn middle burner adjusting preparation |
WO2022270112A1 (en) * | 2021-06-25 | 2022-12-29 | 太 松山 | Corosolic acid capable of improving insulin resistance/sensitivity and enhancing metabolic function and analogue thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3507115B2 (en) * | 1994-02-18 | 2004-03-15 | 株式会社 伊藤園 | Banaba leaf extract and antidiabetic agent |
KR100577094B1 (en) | 2003-12-31 | 2006-05-08 | 주식회사 삼양제넥스 | Method for mass production of secondary metabolites in plant cell culture by treatment of an alkanoic acid or salt thereof |
JP4922550B2 (en) | 2004-03-16 | 2012-04-25 | 株式会社東洋新薬 | Process for producing banaba leaf extract with high corosolic acid content |
KR100481114B1 (en) | 2004-09-04 | 2005-04-07 | 부광메디칼 주식회사 | Pharmaceutical Composition for Decreasing Blood Glucose Level Containing Fermentation Product of the Extract of Banaba, Fenugreek and Bitter Mellon as a Effective Ingredient |
-
2006
- 2006-07-10 KR KR1020060064411A patent/KR100901379B1/en active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013021258A1 (en) | 2011-08-05 | 2013-02-14 | Council Of Scientific & Industrial Research | Anti-tubercular compounds |
CN104007223A (en) * | 2014-06-10 | 2014-08-27 | 山西振东开元制药有限公司 | Quality control method of hawthorn middle burner adjusting preparation |
WO2022270112A1 (en) * | 2021-06-25 | 2022-12-29 | 太 松山 | Corosolic acid capable of improving insulin resistance/sensitivity and enhancing metabolic function and analogue thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100901379B1 (en) | 2009-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6931930B2 (en) | Improved process for producing fucoxanthin and / or polysaccharides from microalgae | |
CN104177370B (en) | A kind of method preparing high-load sesamin from sesame seed meal | |
CN110101728B (en) | Combined extraction method of purslane polysaccharide and total flavonoids based on micelle medium treatment | |
WO2015103974A1 (en) | Method for extracting and purifying l-ergothioneine | |
CN106518829A (en) | Method for separating and purifying dihydromyricetin from ampelopsis grossedentata leaves | |
CN107098942B (en) | Method for subcritical water extraction of kaempferitrin in radish leaves | |
CN102327312A (en) | Method for extracting effective ingredients from leaf, stem and vine of honeysuckle | |
CN102320953B (en) | Method for preparing natural alpha-linolenic acid from crude oil of idesia polycarpa var.vestita diels | |
KR100901379B1 (en) | Method for separation and purification of corosolic acid from corosolic acid-containing materials | |
US3192111A (en) | Method of inducing therapeutic tranquilization with psilocybin and psilocin | |
CN113564094A (en) | Method for increasing intracellular polyphenol accumulation of phellinus igniarius | |
CN104311616A (en) | Method for extracting high-purity esculine and fraxin from Cortex Fraxini | |
CN1110550C (en) | Process for preparing coenzyme Q10 from tobacco | |
JP3806693B2 (en) | Method for recovering pinitol from soybean processing by-products in high yield | |
CN115010618A (en) | Separation and purification method of aureoyl amide alcohol ester capable of reducing uric acid and application thereof | |
CN105962286A (en) | Plant salt containing lavandulaangustifoliamill extract and preparation method of plant salt | |
KR20020015805A (en) | Extracting process of highly purified natural rutin from buckwheat | |
KR101590588B1 (en) | Method of isolating and purifying linolenic acid from perilla oil | |
CN106316797A (en) | Method for preparing hydroxytyrosol by using immobilized enzymic method coupled film technique | |
KR100753982B1 (en) | Method of recovering pinitol in high yield from carob syrup | |
CN108485806A (en) | The preparation method of refined silkworm chrysalis oil | |
CN103882075A (en) | Process for obtaining ginkgolide B by utilizing tremella aurantialba strains to transform ginkgo biloba extracts | |
CN114306122B (en) | Freckle-removing whitening component and application thereof in preparation of cosmetics | |
CN109628516B (en) | Production and extraction process of L-isoleucine | |
CN101781211A (en) | Method for extracting chlorogenic acid from sunflower meal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130227 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140312 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150310 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170306 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180305 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190307 Year of fee payment: 11 |